{"id":"https://openalex.org/W2103149288","doi":"https://doi.org/10.2174/187153006778250019","title":"Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy","display_name":"Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy","alternate_titles":[],"publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2103149288","doi":"https://doi.org/10.2174/187153006778250019","mag":"2103149288","pmid":"https://pubmed.ncbi.nlm.nih.gov/17017974"},"language":"en","primary_location":{"id":"doi:10.2174/187153006778250019","doi":"https://doi.org/10.2174/187153006778250019","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187153006778250019","pdf_url":null,"source":{"id":"https://openalex.org/S4210179974","display_name":"Endocrine Metabolic & Immune Disorders - Drug Targets","issn_l":"1871-5303","issn":["1871-5303","2212-3873"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine\u201a Metabolic &amp; Immune Disorders-Drug Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103149288"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046581820","display_name":"Guido Frumento","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guido Frumento","raw_affiliation_strings":["Istituto Nazionale per la Ricerca sul Cancro, C/o CBA Largo R. Benzi 10, 16132 Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale per la Ricerca sul Cancro, C/o CBA Largo R. Benzi 10, 16132 Genoa, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074433140","display_name":"Tiziana Piazza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tiziana Piazza","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000626730","display_name":"Emma Di Carlo","orcid":"https://orcid.org/0000-0001-7778-1042","observed_orcids":["https://orcid.org/0000-0001-7778-1042"]},"institutions":[{"id":"https://openalex.org/I39387349","display_name":"University of Chieti-Pescara","ror":"https://ror.org/00qjgza05","country_code":"IT","type":"education","lineage":["https://openalex.org/I39387349"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emma Di Carlo","raw_affiliation_strings":["University of Chieti"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chieti","institution_ids":["https://openalex.org/I39387349"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041252659","display_name":"Silvano Ferrini","orcid":"https://orcid.org/0000-0001-7254-2616","observed_orcids":["https://orcid.org/0000-0001-7254-2616"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Silvano Ferrini","raw_affiliation_strings":["Lab. of Immunological Therapy, Istituto Nazionale per la Ricerca sul Cancro, C/o CBA Largo R.Benzi 10, 16132 Genoa Italy.,Italy","A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lab. of Immunological Therapy, Istituto Nazionale per la Ricerca sul Cancro, C/o CBA Largo R.Benzi 10, 16132 Genoa Italy.,Italy","institution_ids":[]},{"raw_affiliation_string":"A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)","institution_ids":["https://openalex.org/I4210146472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3723,"has_fulltext":false,"cited_by_count":94,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94655738,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"6","issue":"3","first_page":"223","last_page":"237"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1256999969482422,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.057100001722574234,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9950000047683716},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.6949999928474426},{"id":"https://openalex.org/keywords/indoleamine-2-3-dioxygenase","display_name":"indoleamine 2,3-dioxygenase","score":0.984000027179718},{"id":"https://openalex.org/keywords/tryptophan-metabolism","display_name":"tryptophan metabolism","score":0.7990000247955322},{"id":"https://openalex.org/keywords/kynurenine","display_name":"kynurenine","score":0.9200000166893005},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8980000019073486},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.781000018119812},{"id":"https://openalex.org/keywords/tr1-cells","display_name":"Tr1 cells","score":0.7400000095367432},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.6869999766349792},{"id":"https://openalex.org/keywords/anti-cd25-antibody","display_name":"anti-CD25 antibody","score":0.734000027179718},{"id":"https://openalex.org/keywords/il-21","display_name":"IL-21","score":0.7310000061988831},{"id":"https://openalex.org/keywords/anti-ctla-4-antibody","display_name":"anti-CTLA-4 antibody","score":0.7229999899864197},{"id":"https://openalex.org/keywords/arginase","display_name":"arginase","score":0.6669999957084656},{"id":"https://openalex.org/keywords/nitric-oxide-synthase","display_name":"nitric oxide synthase","score":0.9929999709129333},{"id":"https://openalex.org/keywords/prostaglandins","display_name":"prostaglandins","score":0.8539999723434448},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8700000047683716},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.9390000104904175},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.6318618655204773},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5821013450622559},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5789269208908081},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5354044437408447},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4697566032409668},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4677462875843048},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4641709327697754},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.44818049669265747},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.41252994537353516},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4008904695510864},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007108","descriptor_name":"Immune Tolerance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007108","descriptor_name":"Immune Tolerance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/187153006778250019","doi":"https://doi.org/10.2174/187153006778250019","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187153006778250019","pdf_url":null,"source":{"id":"https://openalex.org/S4210179974","display_name":"Endocrine Metabolic & Immune Disorders - Drug Targets","issn_l":"1871-5303","issn":["1871-5303","2212-3873"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine\u201a Metabolic &amp; Immune Disorders-Drug Targets","raw_type":"journal-article"},{"id":"pmid:17017974","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17017974","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine, metabolic & immune disorders drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W111751319","https://openalex.org/W2061824209","https://openalex.org/W4310598731","https://openalex.org/W2202794553","https://openalex.org/W2135079975","https://openalex.org/W2952062364","https://openalex.org/W1994296136","https://openalex.org/W2156106286","https://openalex.org/W2753733628","https://openalex.org/W2155094665"],"abstract_inverted_index":{"Tumors":[0],"produce":[1],"several":[2],"factors,":[3,43],"such":[4,52,96],"as":[5,53,97,226],"Prostaglandins":[6],"(PGs),":[7],"Interleukin":[8],"(IL)-10,":[9],"Vascular":[10],"Endothelial":[11],"Growth":[12,17],"Factor":[13,18],"(VEGF)":[14],"and":[15,29,59,121,144,185],"Transforming":[16],"(TGF)-beta,":[19],"which":[20,77,124,199],"may":[21,30,44],"directly":[22],"or":[23,37,92,131,161,174,180],"indirectly":[24],"inhibit":[25],"the":[26,54,60,98,169],"immune":[27,204],"response":[28],"hamper":[31],"immunotherapy.":[32,82,157],"Furthermore,":[33],"cells":[34,51,63,72,84,111,134,164,189],"of":[35,105,150,171],"innate":[36],"adaptive":[38],"immunity,":[39],"recruited":[40],"by":[41,75,93,118,138,168,228],"tumor-derived":[42],"contribute":[45],"in":[46,67,80,109,203,209,231],"immunosuppression.":[47],"Regulatory":[48],"T":[49,86,100,115],"(Treg)":[50],"\"naturally":[55],"occurring\"":[56],"CD4(+)/CD25(+)":[57],"Treg":[58,71,83,163],"IL-10-induced":[61],"Tr1":[62],"are":[64,73,224],"major":[65],"players":[66],"this":[68],"arena.":[69],"Paradoxically":[70],"stimulated":[74],"IL-2,":[76],"is":[78,125,153,200],"used":[79],"tumor":[81,151,233],"suppress":[85,136],"cell":[87,116],"responses":[88,117],"through":[89],"soluble":[90],"factors":[91],"contact-dependent":[94],"mechanisms,":[95,141],"Cytotoxic":[99],"Lymphocyte":[101],"Antigen":[102],"(CTLA)-4-mediated":[103],"induction":[104],"Indoleamine":[106],"2,3-Dioxygenase":[107],"(IDO)":[108],"dendritic":[110],"(DC).":[112],"IDO":[113],"inhibits":[114],"depleting":[119],"Tryptophan":[120],"producing":[122],"Kynurenine,":[123],"toxic":[126],"to":[127,159,192],"lymphocytes.":[128],"Macrophages,":[129],"granulocytes":[130],"myeloid":[132],"suppressor":[133],"(MSC)":[135],"immunity":[137],"other":[139],"enzymatic":[140],"involving":[142],"Arginase":[143],"Nitric":[145],"Oxide":[146],"Synthase":[147],"(NOS).":[148],"Subversion":[149],"immunosuppression":[152],"required":[154],"for":[155],"successful":[156],"Attempts":[158],"block":[160],"eliminate":[162],"have":[165],"been":[166],"made":[167],"use":[170],"chemotherapy,":[172],"anti-CD25":[173,212],"anti-CTLA-4":[175],"antibodies,":[176],"IL-2-toxin":[177],"chimeric":[178],"proteins":[179],"Glucocorticoid-induced":[181],"TNF-like":[182],"Receptor":[183],"(GITR)":[184],"CD134/OX-40":[186],"ligands.":[187],"Tumor":[188],"genetically":[190],"modified":[191],"secrete":[193],"IL-21":[194],"(an":[195],"immune-stimulatory":[196],"\"IL-2-like\"":[197],"cytokine,":[198],"not":[201],"involved":[202],"regulation)":[205],"cured":[206],"experimental":[207,229],"metastases":[208],"combination":[210],"with":[211],"monoclonal":[213],"antibodies":[214],"(mAbs).":[215],"Also":[216],"strategies":[217],"aimed":[218],"at":[219],"blocking":[220],"enzyme-based":[221],"immune-suppressive":[222],"mechanisms":[223],"suitable,":[225],"suggested":[227],"evidences":[230],"mouse":[232],"models.":[234]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103149288","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
